对α-Dystroglycanopathies的糖融合双特异抗体的代谢工程

Xiaotian Zhong1, Guoying Grace Yan1, Apurva Chaturvedi1

  • 1BioMedicine Design, Discovery and Early Development, Pfizer Research and Development, 610 Main Street, Cambridge, MA 02139, USA.

PubMed
概括

补充剂增强了一种新型双特异抗体的基甘修饰,改善其与拉米宁的结合,并为治疗α-基甘病变提供了潜在的可能性.

相关概念视频